Clinical Trial Update: Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 [NA]

View source ↗

Summary

Completed clinical trial evaluating a discharge texting platform (DD-CA) for Hispanic patients with type 2 diabetes and COVID-19 along the US-Mexico border; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Scripps Whittier Diabetes Institute | Conditions: Diabetes Mellitus, Type 2, Covid19 | NA | Status: COMPLETED | Results posted: 2023-09-28